Moleculin Biotech, Inc. (MBRX)
USD 1.88
(1.08%)
USD 1.88
(1.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -24.1 Million | -27.63 Million | -18.95 Million | -17.77 Million | -17.19 Million | -12.2 Million |
| Net Income | -29.76 Million | -29.02 Million | -15.89 Million | -17.35 Million | -13.2 Million | -11.87 Million |
| Depreciation & Amortization | 127 Thousand | 130 Thousand | 164 Thousand | 200 Thousand | 199 Thousand | 68 Thousand |
| Deferred income taxes | -403 Thousand | - | -6.72 Million | -2.34 Million | -4.06 Million | - |
| Stock-based compensation | 1.98 Million | 2.27 Million | 2.37 Million | 1.68 Million | 1.53 Million | 1.14 Million |
| Change in working capital | 1.62 Million | 224 Thousand | 1.03 Million | -41 Thousand | -2.14 Million | 1.61 Million |
| Other non-cash items | 2.33 Million | -1.24 Million | 96 Thousand | 85 Thousand | 476 Thousand | -3.14 Million |
| Investing Cash Flow | -124 Thousand | -67 Thousand | -19 Thousand | -374 Thousand | -51 Thousand | -417 Thousand |
| Investments in PPE | -124 Thousand | -67 Thousand | -19 Thousand | -376 Thousand | -52 Thousand | -417 Thousand |
| Acquisitions | - | - | - | 2000.00 | 1000.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 2.00 | 1.00 | - |
| Financing Cash Flow | 4651.00 | -23 Thousand | 74.72 Million | 22.54 Million | 20.85 Thousand | 12.04 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -25.00 | -23.00 | -23.00 | -17.00 | - | - |
| Common Stock Issuance | 4.16 Million | - | 74.68 Million | 22.56 Million | 20.85 Million | 12.02 Million |
| Other Financing Activities | 4676.00 | -22.97 Thousand | 40.02 Thousand | -11.98 Thousand | 20.85 Thousand | 20 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 403 Thousand | 731 Thousand | 235 Thousand | -1.02 Million | 907 Thousand | 436 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.21 Million | -507 Thousand | 803 Thousand | 983 Thousand | -3.04 Million | 1.17 Million |
| Cash at beginning of period | 43.14 Million | 70.9 Million | 15.17 Million | 10.73 Million | 7.13 Million | 7.71 Million |
| Cash at end of period | 23.55 Million | 43.14 Million | 70.9 Million | 15.17 Million | 10.73 Million | 7.13 Million |
| Capital Expenditure | -124 Thousand | -67 Thousand | -19 Thousand | -376 Thousand | -52 Thousand | -417 Thousand |
| Effect of forex changes on cash | -21 Thousand | -29 Thousand | -24 Thousand | 34 Thousand | -4000.00 | -5000.00 |
| Net cash flow / Change in cash | -19.59 Million | -27.75 Million | 55.73 Million | 4.43 Million | 3.6 Million | -580 Thousand |
| Free Cash Flow | -24.22 Million | -27.7 Million | -18.97 Million | -18.14 Million | -17.25 Million | -12.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.31 Million | -4.97 Million | -29.76 Million | -10.26 Million | -5.6 Million | -5.97 Million |
| Depreciation & Amortization | 31 Thousand | 32 Thousand | 127 Thousand | 35 Thousand | 31 Thousand | 31 Thousand |
| Deferred income taxes | - | - | -403 Thousand | -59 Thousand | -1000.00 | -36 Thousand |
| Stock-based compensation | 453 Thousand | 493 Thousand | 1.98 Million | 479 Thousand | 493 Thousand | 513 Thousand |
| Change in working capital | -418 Thousand | -925 Thousand | 1.62 Million | 3.21 Million | -2.46 Million | 348 Thousand |
| Other non-cash items | -1.91 Million | -396 Thousand | 2.33 Million | 1.19 Million | 1000.00 | -6000.00 |
| Investing Cash Flow | -13 Thousand | - | -124 Thousand | -81 Thousand | -28 Thousand | -15 Thousand |
| Investments in PPE | -13 Thousand | - | -124 Thousand | -81 Thousand | -28 Thousand | -15 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -25 Thousand | - | 4651.00 | 4465.00 | -4.00 | 49.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -25.00 | - | -25.00 | 772.02 Thousand | -4.00 | -21.00 |
| Common Stock Issuance | - | - | 4.16 Million | 3.95 Million | - | 70 Thousand |
| Other Financing Activities | -25 Thousand | - | 4676.00 | 4465.00 | -4000.00 | 70.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 729 Thousand | -394 Thousand | 403 Thousand | 490 Thousand | -2.12 Million | 2.19 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.14 Million | -531 Thousand | 1.21 Million | 2.72 Million | -338 Thousand | -1.84 Million |
| Cash at beginning of period | 16.82 Million | 23.55 Million | 43.14 Million | 24.57 Million | 32.17 Million | 37.26 Million |
| Cash at end of period | 10.84 Million | 16.82 Million | 23.55 Million | 23.55 Million | 24.57 Million | 32.17 Million |
| Capital Expenditure | -13 Thousand | - | -124 Thousand | -81 Thousand | -28 Thousand | -15 Thousand |
| Effect of forex changes on cash | 8000.00 | -9000.00 | -21 Thousand | -6000.00 | -10 Thousand | -1000.00 |
| Net cash flow / Change in cash | -5.97 Million | -6.72 Million | -19.59 Million | -1.02 Million | -7.59 Million | -5.09 Million |
| Free Cash Flow | -5.96 Million | -6.71 Million | -24.22 Million | -5.48 Million | -7.57 Million | -5.14 Million |
NA
AGNCN
OTRK
FLMC
HUSA
IFL